Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

An Efficacy, Safety, Tolerability and Dose Finding Study of XXB750 in Resistant Hypertension Patients.

ClinicalTrials.gov ID: NCT05562934

Public ClinicalTrials.gov record NCT05562934. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 1:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-center, Randomized, Double-blind, Parallel-group, 20-week Dose-finding Study to Evaluate Efficacy, Safety, and Tolerability of XXB750 in Patients With Resistant Hypertension

Study identification

NCT ID
NCT05562934
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
189 participants

Conditions and interventions

Interventions

  • XXB750 drug Biological
  • Placebo Other

Biological · Other

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 7, 2022
Primary completion
Jul 1, 2024
Completion
Aug 26, 2024
Last update posted
Jan 11, 2026

2022 – 2024

United States locations

U.S. sites
18
U.S. states
10
U.S. cities
18
Facility City State ZIP Site status
Pinnacle Research Group Llc Anniston Alabama 36207
Parkway Medical Center Birmingham Alabama 35206
Clinical Trials Research Sacramento Sacramento California 95821-2134
Orange County Research Center Tustin California 92780
Jacksonville Center for Clinical Research Jacksonville Florida 32216
Canvas Clinical Research Lake Worth Florida 33467
Inpatient Research Clinical LLC Miami Lakes Florida 33014
Cardiology Partners Clinical Research Institute Wellington Florida 33449
American Clinical Trials Acworth Georgia 30101
Alliance for Multispecialty Resrch Wichita Kansas 67207
Anderson Medical Research Ft. Washington Maryland 20744
Capitol Cardiology Associates Lanham Maryland 20706
MD Medical Research Oxon Hill Maryland 20745
NexGen Research Lima Ohio 45801
The Research Center of the Upstate Greenville South Carolina 29607
Tennessee Center For Clinical Trials Tullahoma Tennessee 37388
Manassas Clinical Research Center Manassas Virginia 20110
Dominion Medical Associates Richmond Virginia 23219

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 60 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05562934, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 11, 2026 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05562934 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →